Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.79
Delayed Data
As of Mar 24
 +0.295 / +3.47%
Today’s Change
2.48
Today|||52-Week Range
9.25
+38.78%
Year-to-Date
Biotech Premarket Movers: Esperion, Minerva and BioCryst
Mar 21 / TheStreet.com - Paid Partner Content
AstraZeneca's Cancer Drug Lynparza Positive in Phase III
Mar 15 / Zacks.com - Paid Partner Content
Wait for the Pullback on BioCryst Pharmaceuticals
Mar 20 / TheStreet.com - Paid Partner Content
Arena Pharmaceuticals (ARNA) Posts Q4 Earnings, Revenues Up
Mar 15 / Zacks.com - Paid Partner Content
Teva Launches Authorized Generic of Allergan's Minastrin
Mar 17 / Zacks.com - Paid Partner Content
BioCryst Pharmaceuticals (BCRX) Shares March Higher, Can It Continue?
Mar 15 / Zacks.com - Paid Partner Content
Jazz Initiates Phase III Study for Narcolepsy Candidate
Mar 16 / Zacks.com - Paid Partner Content
After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead
Mar 15 / Zacks.com - Paid Partner Content
Conatus Pharma (CNAT) Incurs Wider-than-Expected Loss in Q4
Mar 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close8.49
Today’s open8.61
Day’s range8.52 - 8.87
Volume967,338
Average volume (3 months)1,485,890
Market cap$696.8M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+12.93%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book410.71

Competitors

 Today’s
change
Today’s
% change
MYOVMyovant Sciences Ltd+0.19+1.68%
NDRMNeuroderm Ltd-0.10-0.38%
CRSPCRISPR Therapeutics ...+0.07+0.39%
XBITXBiotech Inc-0.24-1.25%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs